Australia may be the first country to eliminate cervical cancer, but the inequality remains.

Published Date: 08 Mar 2023

Australia has the potential to become the first country in the world to eliminate cancer as a public health problem.

Read Full News

Latest News

Democrats Press RFK Jr. on an Ethics Agreement Change Involving Law Firm Fees

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

Two Procedures May Yield Similar Symptom Relief for Uterine Fibroids

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

Maternal Tdap Blunts Preschoolers' Pertussis Shot Response, but Booster Revives Them

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

FDA Nominee Voices Support for Vaccines at Senate Hearing Scrutinizing Trump's Moves

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

Todays Updates

TRPA1 Antagonist Shows Delayed but Meaningful Effect on IPF Cough Marlies Wijsenbeen, MD, PhD

Marlies Wijsenbeek, MD, PhD, of Erasmus MC discusses BI 1839100, a TRPA1 antagonist, which missed its week-4 endpoint in a phase 2/2b trial.

Mepolizumab Reduces Systemic Corticosteroid Exposure in Eosinophilic COPD Chelsie Derman

In pooled phase 3 data, mepolizumab lowered mean yearly systemic corticosteroid exposure by 178.97 mg in patients with a BEC of ≥150 cells/µL.

ASPEN: Sputum Color Associated With Bronchiectasis Disease Activity Victoria Johnson

A post hoc analysis linked more purulent patient-reported sputum to higher neutrophil elastase activity and greater bronchiectasis disease activity.

Sphingolipid Profiles May Distinguish IPF from Fibrotic HP

Sphingolipid Profiles May Distinguish IPF from Fibrotic HP

CHEST 2026: Day 1 Recap — 5 Headlines to Know

CHEST 2026: Day 1 Recap — 5 Headlines to Know

PAH Combination Therapy and Escalation: Clinical Forum Perspectives

PAH Combination Therapy and Escalation: Clinical Forum Perspectives

APP Experts Discuss Earlier Biologic Use in Asthma and COPD

APP Experts Discuss Earlier Biologic Use in Asthma and COPD

Todays Updates

TRPA1 Antagonist Shows Delayed but Meaningful Effect on IPF Cough Marlies Wijsenbeen, MD, PhD

Marlies Wijsenbeek, MD, PhD, of Erasmus MC discusses BI 1839100, a TRPA1 antagonist, which missed its week-4 endpoint in a phase 2/2b trial.

Mepolizumab Reduces Systemic Corticosteroid Exposure in Eosinophilic COPD Chelsie Derman

In pooled phase 3 data, mepolizumab lowered mean yearly systemic corticosteroid exposure by 178.97 mg in patients with a BEC of ≥150 cells/µL.

ASPEN: Sputum Color Associated With Bronchiectasis Disease Activity Victoria Johnson

A post hoc analysis linked more purulent patient-reported sputum to higher neutrophil elastase activity and greater bronchiectasis disease activity.

Sphingolipid Profiles May Distinguish IPF from Fibrotic HP

Sphingolipid Profiles May Distinguish IPF from Fibrotic HP

CHEST 2026: Day 1 Recap — 5 Headlines to Know

CHEST 2026: Day 1 Recap — 5 Headlines to Know

PAH Combination Therapy and Escalation: Clinical Forum Perspectives

PAH Combination Therapy and Escalation: Clinical Forum Perspectives

APP Experts Discuss Earlier Biologic Use in Asthma and COPD

APP Experts Discuss Earlier Biologic Use in Asthma and COPD

Latest News

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

News All Time

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV

Combo could offer an alternative for those who can't take existing single-tablet regimens

Her Breast MRI Was Approved, but That Didn't Mean Her Insurance Would Pay

High-risk patients face steep, surprise bills for preventive breast MRIs

Lionel Richie Hospitalized; CDC Challenges Measles Toll; Vitamin K Refusals Rise

Health news and commentary gathered by MedPage Today staff

Nurse Who Saved Baby in Pakistan Hospital Fire Wishes She Could Have Saved the Rest

"I acted as a mother," she said

Gloria Steinem on Women's Rights, Abortion Politics, and Being Called the B-Word

And what she thought about Roe v. Wade being overturned

Judge Declares Mistrial in Lindsay Clancy Case

Defense attorney said she was suffering from postpartum psychosis when she strangled her kids

Judge Sends Deadlocked Lindsay Clancy Jurors Home

Foreperson said a single juror won't follow the court's instructions about reasonable doubt

One of the Lindsay Clancy Trial's Most Instructive Moments for Physicians

The author of a medical record doesn't always retain ownership of its meaning

Breast Cancer Drug Wins Approval Despite Rejection by Agency Advisors

Oral SERD camizestrant lands indication for use in novel first-line treatment strategy

Trump Pardon Sought for Clancy; Sen. Marshall's Medical Debt Suits; Lasker Winners

Health news and commentary gathered by MedPage Today staff

An Appeals Court Is Considering a Push to Restrict Most Common Abortion Method

The political situation is tricky for President Trump

Ectopic Pregnancy Deaths Have Nearly Doubled. It's Worse in Abortion-Ban States.

"This is a potentially profound consequence of the regulation," said one abortion policy expert

Residency Software Developer Sues Doctor Who Helped Launch a Competing Product

AAMC-partnered Thalamus goes after key players in ResidencyCAS

Bipartisan Campaign Pledges $100M to Cut U.S. Maternal Mortality Rate in Half

Problem is "eminently solvable," says president of Healthy Moms, Healthy Babies America

Recommended News For You

High numbers of rural patients cross state lines for cancer care

Higher Risk of Kidney Cancer Recurrence After Ablative Therapy

New First-Line Option for Advanced ALK-Positive Lung Cancer

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

Enzalutamide vs Abiraterone: Which is Better for mCSPC?

Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.

A garden can save your life

Recommended Articles For You

Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring 

Toxicity Surveillance for Bispecific Cancer Therapies 

Teaching Coagulation Pathways Through Visual Sequencing: A Comprehensive Review for Clinicians 

Tumor Microenvironment Reprogramming in Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

2.

Sevabertinib Approved for First-Line Mutated NSCLC

3.

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

4.

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs

5.

AI can identify women at risk of breast cancer years in advance: Study

1.

Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy

2.

Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications

3.

Hematopoietic Stem Cell Activity Biomarkers in Aging

4.

Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives

5.

The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder 

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

2.

A New Era in Managing Cancer-Associated Thrombosis

3.

Emerging Concepts in Hematology

4.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot